Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000648998 | SCV000770819 | pathogenic | D-2-hydroxyglutaric aciduria 1 | 2017-12-19 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 3-10 of the D2HGDH gene. The 5' boundary is likely confined to intron 2. The 3' end of this event is unknown as it extends through the termination codon beyond the assayed region for this gene and may encompass additional genes. While this deletion is not anticipated to result in nonsense mediated decay, it is expected to create a truncated protein product or disrupt mRNA translation. This variant has not been reported in the literature in individuals with D2HGDH-related disease. This deletion encompasses over 75% of the D2HGDH protein and includes most of the variants associated with D-2-hydroxyglutaric aciduria (PMID: 16037974, 20020533). For these reasons, this variant has been classified as Pathogenic. |